Skip to main content
. 2022 Jan 5;104:108502. doi: 10.1016/j.intimp.2021.108502

Fig. 3.

Fig. 3

COX-2 immunocontent in the ICU group (ICU), outpatients (OP), patients with COVID-19 history (HP), and healthy controls (HC) (A). Representative blots and Ponceau S stained are shown in Figure B. Statistically significant differences were determined by Kruskal-Wallis test followed by Dunn's post hoc test for multiple comparisons.